Gracell Biotechnologies
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Gracell Biotechnologies's balance sheet done over the years? Its assets were worth $1,656,276,000 last year, which is less than in the previous period. 17% of Gracell Biotechnologies’s total assets is currently financed by debt. Its liabilities reached the amount of $280,511,000, which means an increase by 21% compared compared to last year.

Debt to Assets

Gracell Biotechnologies Inc. (NASDAQ:GRCL): Debt to assets
2018 148518000 146.13M 98.4%
2019 412217000 156.86M 38.05%
2020 964950000 145.28M 15.06%
2021 2060137000 232.76M 11.3%
2022 1656276000 280.51M 16.94%

GRCL Balance Sheet (2018 – 2022)

2022 2021 2020 2019 2018
Assets
Current assets:
Cash and cash equivalents
1.45B1.82B754.30M312.05M11.89M
Short term investments
3.55M3.61M18.74M4.2M102M
Net receivables
26.33M40.69M30.96M13.77M6.2M
Inventory
-26.33M8.69M-30.96M9.38M7.70M
Other current assets
37.55M3.07M42.41M939K170K
Total current assets
1.49B1.88B815.46M340.35M127.96M
Non-current assets:
Property, Plant and Equipment
144.67M173.43M119.08M71.86M20.55M
Goodwill
00000
Intangible assets
00000
Long term investments
00000
Other non-current assets
15.84M1.61M30.39M00
Total non-current assets
160.52M175.05M149.48M71.86M20.55M
Total assets
1.65B2.06B964.95M412.21M148.51M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
2.90M2.90M000
Short term debt
129.98M86.00M50.96M00
Total current liabilities
220.64M155.12M93.36M18.16M7.44M
Non-current liabilities:
Long term debt
52.99M69.17M51.92M138.69M138.69M
Deferred tax
00000
Other non-current liabilities
6.87M8.46M000
Total non-current liabilities
59.86M77.64M51.92M138.69M138.69M
Total liabilities
280.51M232.76M145.28M156.86M146.13M
Data sourceData sourceData source